Literature DB >> 23954740

Increased frequency of T cells expressing IL-10 in Alzheimer disease but not in late-onset depression patients.

Karen Cecília Torres1, Patrícia Araújo Pereira, Giselle Sabrina Lima, Isadora Cristina Bozzi, Vitor Bortolo Rezende, Maria Aparecida Bicalho, Edgar Nunes Moraes, Débora Marques Miranda, Marco Aurélio Romano-Silva.   

Abstract

Higher risk of dementia is expected for patients with late onset depression (LOD) history. The IL-10 polymorphisms are associated with Alzheimer disease (AD). On the other hand, there is no study associating IL-10 polymorphisms to LOD. This study aimed to investigate the -1082G/A polymorphism association in LOD, AD patients and controls and also the peripheral expression of IL-10 in CD4+ T cells. It was done in a case-control study comparing immune system phenotype and genetic polymorphism association among control individuals, LOD and AD patients. Participants were 569 subjects composed the genetics sample (249 AD, 222 LOD and 98 controls) from a tertiary medical center based on Belo Horizonte, Brazil. Flow cytometry analysis was performed in 55 people (22 AD patients, 11 LOD patients and 22 controls). A real time PCR for IL-10 SNP (rs 1800896) through genotyping analysis and flow cytometry evaluation of CD4+ T cells expressing IL-10 was done. An increased CD4+ T cells expressing IL-10 were detected only in the AD group. There was no difference detected in allele or genotype analysis for IL-10 polymorphism among LOD, AD patients or controls. IL-10 might have a role in the modulation of immune response in AD patients, however it is not presented in LOD population.
© 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  AD; Ab; Alzheimer disease; BBB; COPD; GDS; Geriatric Depression Scale; IL-10; IL-10 in CD4+ T cells; IL-10 polymorphism; LOD; Late-Onset Depression; MMSE; Mini-mental State Examination; PCR; SNP; beta amyloid peptide; blood–brain-barrier; chronic obstructive pulmonary disorder; interleukin 10; late onset depression; polymerase chain reaction; single nucleotide polymorphism

Mesh:

Substances:

Year:  2013        PMID: 23954740     DOI: 10.1016/j.pnpbp.2013.07.021

Source DB:  PubMed          Journal:  Prog Neuropsychopharmacol Biol Psychiatry        ISSN: 0278-5846            Impact factor:   5.067


  13 in total

1.  Association of anti-inflammatory cytokine IL10 polymorphisms with motoric cognitive risk syndrome in an Ashkenazi Jewish population.

Authors:  Sanish Sathyan; Nir Barzilai; Gil Atzmon; Sofiya Milman; Emmeline Ayers; Joe Verghese
Journal:  Neurobiol Aging       Date:  2017-06-19       Impact factor: 4.673

2.  Long-term kinetics of AA amyloidosis and effects of inflammatory restimulation after disappearance of amyloid depositions in mice.

Authors:  N Muhammad; T Murakami; Y Inoshima; N Ishiguro
Journal:  Clin Exp Immunol       Date:  2015-04-23       Impact factor: 4.330

Review 3.  Emerging Role of PD-1 in the Central Nervous System and Brain Diseases.

Authors:  Junli Zhao; Alexus Roberts; Zilong Wang; Justin Savage; Ru-Rong Ji
Journal:  Neurosci Bull       Date:  2021-04-20       Impact factor: 5.271

Review 4.  Regulation of Neuroinflammation through Programed Death-1/Programed Death Ligand Signaling in Neurological Disorders.

Authors:  Shangfeng Zhao; Fengwu Li; Rehana K Leak; Jun Chen; Xiaoming Hu
Journal:  Front Cell Neurosci       Date:  2014-09-03       Impact factor: 5.505

5.  Genetic polymorphisms of interleukin genes and the risk of Alzheimer's disease: An update meta-analysis.

Authors:  Myung-Jin Mun; Jin-Ho Kim; Ji-Young Choi; Won-Cheoul Jang
Journal:  Meta Gene       Date:  2016-01-11

Review 6.  Genetic Contributions of Inflammation to Depression.

Authors:  Jacob Barnes; Valeria Mondelli; Carmine M Pariante
Journal:  Neuropsychopharmacology       Date:  2016-08-24       Impact factor: 7.853

7.  Fasudil in Combination With Bone Marrow Stromal Cells (BMSCs) Attenuates Alzheimer's Disease-Related Changes Through the Regulation of the Peripheral Immune System.

Authors:  Jiezhong Yu; Yuqing Yan; Qingfang Gu; Gajendra Kumar; Hongqiang Yu; Yijin Zhao; Chunyun Liu; Ye Gao; Zhi Chai; Jasleen Chumber; Bao-Guo Xiao; Guang-Xian Zhang; Han-Ting Zhang; Yuqiang Jiang; Cun-Gen Ma
Journal:  Front Aging Neurosci       Date:  2018-07-16       Impact factor: 5.750

Review 8.  Protective and Regenerative Roles of T Cells in Central Nervous System Disorders.

Authors:  Frances L Evans; Marie Dittmer; Alerie G de la Fuente; Denise C Fitzgerald
Journal:  Front Immunol       Date:  2019-09-12       Impact factor: 7.561

Review 9.  Peripheral immune system in aging and Alzheimer's disease.

Authors:  Wei Cao; Hui Zheng
Journal:  Mol Neurodegener       Date:  2018-10-03       Impact factor: 14.195

10.  Breaking immune tolerance by targeting Foxp3(+) regulatory T cells mitigates Alzheimer's disease pathology.

Authors:  Kuti Baruch; Neta Rosenzweig; Alexander Kertser; Aleksandra Deczkowska; Alaa Mohammad Sharif; Amit Spinrad; Afroditi Tsitsou-Kampeli; Ayelet Sarel; Liora Cahalon; Michal Schwartz
Journal:  Nat Commun       Date:  2015-08-18       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.